Technical Analysis for GRFS - Grifols, S.A.

Grade Last Price % Change Price Change
grade F 18.94 -1.97% -0.38
GRFS closed down 3.88 percent on Wednesday, May 27, 2020, on approximately normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down
Historical GRFS trend table...

Date Alert Name Type % Chg
Fell Below 20 DMA Bearish -1.97%
Fell Below 50 DMA Bearish -1.97%
MACD Bearish Centerline Cross Bearish -1.97%
Overbought Stochastic Strength -1.97%
Down 3 Days in a Row Weakness -1.97%
Stochastic Sell Signal Bearish -5.77%
20 DMA Support Bullish -5.77%
Multiple of Ten Bullish Other -5.77%
Overbought Stochastic Strength -5.77%
MACD Bullish Centerline Cross Bullish -8.10%

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:


Grifols, S.A., a specialty biopharmaceutical company, develops, manufactures, and distributes a range of plasma derivative products primarily in the European Union, Spain, the United States, and Canada. It specializes in providing infusion solutions, nutrition products, medical devices, and diagnostic instrumentation and reagents for use in hospitals and clinics. The company operates in four divisions: Bioscience, Diagnostic, Hospital, and Raw Materials and Others. The Bioscience division manufactures and sells plasma derivatives for therapeutic use, including the reception, analysis, quarantine, classification, fractionation, and purification of plasma; and sells and distributes end products. This division offers plasma products, such as IVIG, Factor VIII, A1PI, and albumin; and intramuscular immunoglobulins, ATIII, Factor IX, and plasma thromboplastin components. The Diagnostic division focuses on researching, developing, manufacturing, and marketing in vitro diagnostics products, such as analytical instruments and reagents for diagnostics, as well as blood bank products. This division serves blood donation centers, clinical analysis laboratories, and hospital immunohematology services. The Hospital division manufactures and installs products used by and in hospitals comprising parenteral solutions, and enteral and parenteral nutritional fluids. The Raw Materials and Others division engages in the sale of intermediate pastes and plasma to third parties. The company's products and services are used by healthcare providers to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases, and a range of other medical conditions. The company was formerly known as Probitas Pharma, S.A. and changed its name to Grifols, S.A. in 2005. Grifols, S.A. was founded in 1940 and is headquartered in Barcelona, Spain.
Medicine Biopharmaceutical Medical Specialties Infectious Diseases Healthcare Providers Antibody Nutrition Products European Union Hemophilia Transfusion Medicine End Products Ibex 35 In Vitro Diagnostics Infusion Solutions Plasma Products

Is GRFS a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 25.73
52 Week Low 13.4
Average Volume 808,433
200-Day Moving Average 21.52
50-Day Moving Average 19.81
20-Day Moving Average 19.95
10-Day Moving Average 20.03
Average True Range 0.79
ADX 22.48
+DI 15.35
-DI 30.61
Chandelier Exit (Long, 3 ATRs ) 18.77
Chandelier Exit (Short, 3 ATRs ) 20.09
Upper Bollinger Band 20.91
Lower Bollinger Band 18.98
Percent B (%b) 0.17
BandWidth 9.67
MACD Line -0.04
MACD Signal Line -0.05
MACD Histogram 0.0146
Fundamentals Value
Market Cap 26.4 Billion
Num Shares 1.37 Billion
EPS 0.49
Price-to-Earnings (P/E) Ratio 39.43
Price-to-Sales 5.73
Price-to-Book 6.87
PEG Ratio 1.34
Dividend 0.33
Dividend Yield 1.71%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 20.34
Resistance 3 (R3) 20.44 20.20 20.17
Resistance 2 (R2) 20.20 19.94 20.15 20.11
Resistance 1 (R1) 19.76 19.78 19.64 19.66 20.06
Pivot Point 19.52 19.52 19.46 19.47 19.52
Support 1 (S1) 19.08 19.26 18.96 18.98 18.58
Support 2 (S2) 18.84 19.10 18.79 18.53
Support 3 (S3) 18.40 18.84 18.47
Support 4 (S4) 18.30